Phase 2b dose-finding study of SER150.
Phase of Trial: Phase II
Latest Information Update: 18 Jul 2017
At a glance
- Drugs SER 150 (Primary)
- Indications Diabetic nephropathies
- Focus Adverse reactions
- 18 Jul 2017 New trial record
- 28 Feb 2017 According to a Serodus media release, this study is expected to start in 2018.